Feds Have Until Tomorrow to Oppose Sanofi’s Request for Stay Against 340B ADR Proceedings

U.S. Chief District Judge Freda Wolfson gave government lawyers until the end of the day tomorrow to weigh in on Sanofi’s request for emergency protection from 340B ADR proceedings.

A federal district judge has given government lawyers until Wednesday to weigh in on drug manufacturer Sanofi’s request for emergency protection from being brought before a 340B administrative dispute resolution panel.

U.S. Chief District Judge Freda Wolfson gave the U.S.

Read More »

Sanofi Seeks Emergency Stay Blocking 340B Dispute Resolution Proceedings

Drug manufacturer Sanofi yesterday asked a federal judge in New Jersey for an emergency stay against 340B administrative dispute resolution (ADR) proceedings against it brought by health centers.

Drug manufacturer Sanofi yesterday asked a federal judge in New Jersey to stay 340B administrative dispute resolution (ADR) proceedings against it brought by health centers seeking to overturn Sanofi’s restrictions on 340B pricing when covered entities use contract pharmacies.

Sanofi

Read More »

Judge Sets Deadlines for Briefs in 340B Contract Pharmacy Antitrust Suit

U.S. Chief District Judge Elizabeth Wolford has set deadlines for briefs in a New York health center's 340B contract pharmacy antitrust lawsuit against four drug companies.

A federal district judge in Rochester, N.Y., has given four insulin and diabetes drug manufacturers until Oct. 29 to file a motion to dismiss an upstate New York health center’s lawsuit claiming the manufacturers conspired to stop offering 340B pricing

Read More »

New Judge Assigned to PhRMA’s Lawsuit Challenging Arkansas’s First-of-Its-Kind 340B Nondiscrimination Law

U.S. Senior District Judge Billy Roy Wilson has been assigned to PhRMA's lawsuit challenging Arkansas’s 340B nondiscrimination act.

A new federal district judge has been assigned to Pharmaceutical Research and Manufacturers of America’s (PhRMA) lawsuit challenging Arkansas’s 340B nondiscrimination act.

PhRMA’s case, filed on Sept. 29, was initially assigned to U.S. District Judge Lee Rudofsky, a Trump appointee.

Read More »

Federal Appeals Court Hears Arguments in Case Involving Walgreens’s 340B Program

The U.S. Court of Appeals for the Fourth Circuit heard arguments in J.R. v. Walgreens Boots Alliance on Sept. 22.

A federal appeals court is considering some South Carolina Walgreens customers’ claims that Walgreens, in its capacity as a 340B contract pharmacy and as a 340B contract pharmacy third-party administrator (TPA), violated their privacy rights under South Carolina law.

The

Read More »

PhRMA Asks Federal Court to Strike Down Arkansas’ Novel 340B Nondiscrimination Law

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.

Pharmaceutical Research and Manufacturers of America (PhRMA) asked a federal district court yesterday to rule that Arkansas’s 340B nondiscrimination act does not require drug manufacturers “to offer price discounts under the 340B program to contract pharmacies in Arkansas.”

PhRMA also

Read More »

340B Dispute Resolution Process is Constitutional, Feds Tell Court

A recent U.S. Supreme Court ruling confirms that the 340B administrative dispute resolution process is constitutional, government lawyers told a federal district judge this month.

A recent U.S. Supreme Court ruling about administrative law judges who hear patent disputes confirms that rules establishing the 340B program’s administrative dispute resolution (ADR) process are constitutional, government lawyers told a federal district judge this month.

Under the 340B

Read More »

Hospital Groups and Drug Industry Vendor File Briefs in Sanofi’s 340B Contract Pharmacy Suit

A federal district judge this week let six hospitals groups and a drug industry vendor file amicus briefs in Sanofi's 340B contract pharmacy lawsuit.

A federal district judge this week gave six hospital groups and a drug industry services provider permission to separately offer their expert advice in drug manufacturer Sanofi’s 340B contract pharmacy lawsuit.

In a friend-of-the-court brief, the hospital groups accused

Read More »

Judge Rejects Novartis’ Request to Speed Up Hearing in 340B Contract Pharmacy Lawsuit

A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies

A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies.

Read More »

Parties at Center of Contract Pharmacy Standoff React to HHS OIG Referral

HRSA's decision to refer six drug manufacturers to the HHS OIG has elicited a variety of reactions.

The decision by the U.S. Health Resources & Services Administration (HRSA) to refer six drug manufacturers to the U.S. Health and Human Services Department of the Office of The Inspector General (HHS OIG) for refusing to offer 340B discounts to

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live